HEALTH

Bausch & Lomb appoints new VP and global president, vision care

BY Michael Johnsen

ROCHESTER, N.Y. Bausch & Lomb on Monday named Peter Valenti corporate VP and global president, vision care, effective July 1.

Valenti replaces Stuart Heap, who has chosen to step down from his current role with B&L for personal reasons, effective June 30. Heap will remain an active strategic advisor to the company.

“[Valenti] possesses a mix of deep leadership experience, healthcare and eye health expertise, and has already made significant contributions to helping grow the B&L business during his brief tenure,” stated Gerald Ostrov, B&L chairman and CEO. “At the same time, we thank [Heap] for his significant contributions to the company as he chooses to spend more time with his family.”

Valenti joined B&L in January 2009 as president, North America, vision care. Before being named to that role, Valenti served as VP and GM, surgical devices (U.S.), for Covidien, where he led the U.S. sales and marketing strategy for the $1 billion product portfolio from 2007 to 2008.

In conjunction with Valenti’s transition to his new role, the company has named Steven Robins as president, North America, vision care.

Robins joins B&L with approximately two decades of consumer healthcare experience at leading companies such as Johnson & Johnson, Pfizer and Warner Lambert. Most recently, he was GM, Johnson & Johnson Consumer Healthcare Canada, and a VP of the Johnson & Johnson Consumer Group, with responsibility for a number of health and beauty brands such as Listerine, Reach, Band-Aid, Stayfree and Purell.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

FDA grants clearance of market, sale of new allergy-friendly latex condom

BY Michael Johnsen

WILMINGTON, Del. Vystar and Alatech Healthcare on Friday announced that the Food and Drug Administration granted 510(k) clearance to market and sell Alatech’s Envy condom manufactured with Vytex Natural Rubber Latex.

The Envy condom will be the first consumer medical product available in the U.S. made from Vystar’s patented Vytex NRL, which has less than 2 micrograms/dm2, virtually undetectable levels, of the antigenic proteins that can cause an allergic response, while retaining and improving upon all the desirable qualities of latex.

The Envy condom will carry labeling that will reflect the lowest antigenic protein content currently available in a natural rubber latex medical device in the U.S. Natural rubber latex contains more than 200 proteins, similar to other natural plant materials, of which 13 are known allergens. The Vytex NRL process was created to significantly reduce these known proteins. Vystar’s business model is to assist all manufacturers in marketing the Vytex component of their products.

Alatech will market and sell the Envy NRL condom to retailers and through other distribution channels, and expects the product to be available to consumers in the coming months.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

American Red Cross survey: Adults are worried about swine flu, taking precaution

BY Michael Johnsen

WASHINGTON One-in-three Americans are worried about the H1N1 outbreak, but more than half of the people are paying extra attention to good hygiene and preparedness as a way of protecting themselves from the virus, according to a poll released Wednesday by the American Red Cross.

The survey of 1,004 U.S. adults, taken May 1 to 4, shows that four-out-of-five of those surveyed reported that they are following the flu story very or fairly closely, and 36% said they were either very worried (8%) or somewhat worried (28%) about this flu virus.

But the flu outbreak has prompted people to take more steps to prevent the spread of the virus, with 55% saying they are paying extra attention to proper hand washing; 48% covering their coughs more, and 41% disinfecting surfaces more. In addition, more than one in three have used hand sanitizers more and made an extra effort to avoid touching their mouth, nose and eyes.

“This swine flu virus continues to have the potential to spread throughout the U.S.,” stated Scott Conner, SVP American Red Cross Preparedness and Health and Safety Services. “Families, businesses and organizations should continue to follow good public health practices and to review and update their preparedness plans. … Even if this version of the swine flu virus is not as dangerous as initially feared, public health officials worry that it could come back in a more severe form later this year. The Red Cross believes that prudent preparedness steps now can help keep families healthy throughout the year.”

The survey did show that 11% said someone in the household had gone to work or school when they had the seasonal flu, and 22% indicated that they have gone to school or work within five days of having flu symptoms.

Two-in-five are misguided about flu shots as 39% incorrectly believe that a seasonal flu shot offers some protection from H1N1.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?